ATNF - Balance Sheet - 180 Life Sciences Corp.

Current Liabilities	3.5 M
Accounts Payable	1.93 M
Short-Term Debt	148 K
Other Current Liabilities	1.42 M
Non-Current Liabilities	6.62 K
Long-Term Debt	0
Other Non-Current Liabilities	6.62 K

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	4.6	2.0	7.0	8.2	2.1	83.4 K	0.6	0.4
Short Term Investments	0	0	0	0	0	11.9	118.2	116.6
Receivables	0	0	0	0	0	0	0	0
Inventory	0	0	(0.6)	2.2	1.1	0.3	0	0
Other Current Assets	0	1.7	1.3	3.0	1.9	0.7	0.4	0
Total Current Assets	5.1	3.6	8.9	11.2	4.0	0.7	1.0	0.5
PP&E	0	0	0	0	0	54.3 K	22.1 K	0
Intangible Assets	7.6	1.6	10.7	14.5	14.6	14.7	0.4	0
Goodwill	0	0	0	37.0	36.9	36.4	0	0
Long Term Investments	0	0	0	0	0	(17.5)	0	0
Other Long Term Assets	0	0	(15.7)	(9.7)	(9.7)	12.5	17.6 K	116.6
Other Assets	0	0	0	0	0	0	0	0
Total Assets	12.8	5.3	19.7	62.7	55.5	51.9	1.5	117.1
LIABILITIES
Accounts Payable	1.9	1.9	1.8	0.6	8.5	4.1	0.2	0
Short Term Debt	0.1	1.0	1.3	1.9	3.7	3.5	0	0
Other Current Liabilities	1.4	2.1	2.5	17.2	9.2	2.0	8.8	0.1
Total Current Liabilities	3.5	5.1	5.7	19.7	21.4	9.6	9.1	0.2
Long Term Debt	0	19.9 K	31.2 K	48.2 K	0.1	0	0	0
Deferred Tax Income	0	0.3	2.6	3.6	3.7	3.7	0	0
Other Liabilities	0	0	0	0	3.7	0	0	4.0
Total Liabilities	3.5	5.4	8.3	23.4	25.2	13.3	9.1	4.2
EQUITY
Common Stock	318	54	375	3.4 K	2.62 K	1.38 K	0	107.8
Retained Earnings	(141.5)	(127.3)	(107.4)	(68.7)	(48.4)	(37.5)	(12.1)	0.1
Other Accumulative Comprehensive Income/Loss	(2.9)	(2.9)	(2.9)	0.8	0.6	0.2	0.3	0
Total Equity	9.3	(0.1)	11.3	39.3	30.3	38.6	(7.7)	5.0
Total Liabilities and Equity	12.8	5.3	19.7	62.7	55.5	51.9	1.5	117.1
SHARES OUTSTANDING
Common Shares Outstanding	0.9	0.4	100 K	82 K	47 K	29 K	10 K	10 K

Free